Rosemont Pharmaceuticals, global leaders in liquid medicine manufacture, has invested a seven-figure sum into a significant development for its business operations by opening an Innovation Centre adjacent to the existing production facility.
The agreement was signed at the British Embassy in Kuwait by Mark Vallance, Rosemont Pharmaceuticals’ Head of International Sales and Rashed Khazal, Kuwait-Saudi Pharmaceutical Industries Co. (KSPICO) Chairman and Managing Director.
Rosemont is extremely pleased to announce the launch of our Art Competition in conjunction with University of Leeds this March, which offers all students an opportunity to design artwork for Rosemont’s brand new Innovation Centre.
Launched 19 December 2021 inside the Telegraph’s Stella magazine
On December 1st Rosemont Pharmaceuticals received Marketing Authorisation for Glycopyrronium Bromide 1mg/5ml Oral Solution. This prescription only medicinal product is indicated for symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders. Sialorrhoea, or chronic pathological drooling, is the unintentional loss of saliva from the mouth and is most commonly caused by neuromuscular conditions.
Rosemont Pharmaceuticals has completed the acquisition of Essential Pharma Liquids Limited from Essential Pharmaceuticals Limited.
The Lloyds Bank British Business Excellence Awards (BBEA) celebrates and showcases the resilience, innovation and creativity of British businesses.
Sales growth of 49% since June ’20, with significant investment secured to support future business ambitions
We are overjoyed, humbled and proud to have won ‘Product Launch of The Year’ in the Pharmacy Product of the Year Awards 2021! A fantastic achievement by all
#communitypharmacy #pharmacy #awards #pharmaceuticals
New Chief Commercial Officer, Eric Vick, and Chief Financial Officer, Tim Busby.
